China's drive to build an AI-native generation is gaining traction, per Reuters.
The U.S. FDA rejected a cancer drug invented in China, dealing a blow to Beijing's biotech sector, FT reports.
Beijing's AI ambitions are supported by figures like Jensen Huang, who built a backdoor route to keep China in the race, WSJ notes.
Meanwhile, struggling bookshops in China are selling coffee to stay afloat, SCMP reports.
People were searching for this story in 2 of the 54 countries E14 follows on Google Trends. Rank = its place among the searches that trended in that country within four hours of it.
E14 places every story on a stack of fifteen floors, from the fields under everything to the planet acting as one. This one sits on E8, minds; the pressure it names: AI and biotech challenges. Its words also reach E12 states, E11 organizations, E9 cultures, E6 organisms and E10 institutions.
Here it is a dynamic between minds, states and organizations: AI-native generation (E8 minds), with Beijing's AI ambitions (E12 states), and Jensen Huang (E11 organizations).
The floor of minds and discovery. In this briefing: AI-native generation.
The floor of states and force. In this briefing: Beijing's AI ambitions.
The floor of companies and infrastructure. In this briefing: Jensen Huang.
The floor of culture and meaning. In this briefing: bookshops.
The floor of bodies and health. In this briefing: cancer drug.
The floor of money and rules. In this briefing: biotech sector.